The Group's principal activity is to focus on developing and commercializing novel neurostimulation therapies for a broad range of neurological diseases and disorders. The Groups proprietary system, the RenovaTMCortical Stimulation System, is designed to deliver targeted electrical stimulation to the outermost layer of the brain, or the cortex, in a process called cortical stimulation. The Groups product candidate, the Renova-ST Cortical Stimulation System or Renova-ST is designed to enhance recovery of hand and arm motor function in patients who have suffered a stroke. It is also studying therapeutic applications for its cortical stimulation therapy for other neurological conditions including: stroke-related aphasia, which is an impaired ability to speak following a stroke. It is currently conducting a pivotal trial for stroke motor recovery called EVEREST, using its Renova ST. The Group is in its development stage. The Group operates in the United States.
Alacra Alerts:
Receive alerts on the latest reports on Northstar Neuroscience Inc
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
